- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
Butyrophenone is a class of drugs used to treat gastrointestinal disorders. It is a type of antipsychotic drug that works by blocking dopamine receptors in the brain. It is used to treat conditions such as nausea, vomiting, and abdominal pain. It is also used to treat irritable bowel syndrome, Crohn's disease, and ulcerative colitis. Butyrophenone is available in both oral and injectable forms. It is usually taken once or twice a day, depending on the condition being treated.
Butyrophenone is a widely used drug in the gastrointestinal market. It is used to treat a variety of conditions, from nausea and vomiting to irritable bowel syndrome and Crohn's disease. It is generally well tolerated and has few side effects.
Some companies in the Butyrophenone market include Pfizer, Novartis, Merck, and GlaxoSmithKline. Show Less Read more